Skip to main content
. Author manuscript; available in PMC: 2010 Nov 23.
Published in final edited form as: Microcirculation. 2009 Apr;16(3):203–212. doi: 10.1080/10739680802502423

Table 2.

Skeletal muscle capillarization in chronic stroke subjects and controls with normal (NGT) and impaired (IGT) glucose tolerance

Stroke subjects(n = 12) Controls


Hemiparetic Nonparetic IGT (n = 12) NGT (n = 12)
Overall share factor 3.09 ± 0.04§ 2.98 ± 0.05 3.05 ± 0.03 2.99 ± 0.05
 Type I 3.12 ± 0.07§, 2.94 ± 0.04 3.01 ± 0.03 2.96 ± 0.05
 Type IIa 3.07 ± 0.04 3.02 ± 0.05 3.08 ± 0.05 3.00±0.06
 Type IIx 3.01 ± 0.04 3.09 ± 0.04 3.15 ± 0.05 3.14 ± 0.05
Overall capillary contacts 3.38 ± 0.24 , 4.51 ± 0.36 4.02 ± 0.22 4.57 ± 0.23
 Type I 3.83 ± 0.22§, 4.85 ± 0.38 4.47 ± 0.23 4.84 ± 0.25
 Type IIa 3.23 ± 0.20*, 4.06 ± 0.41 3.72 ±.022 4.28 ± 0.25
 Type IIx 2.97 ± 0.27* 3.43 ± 0.38 3.17 ± 0.15 3.52 ± 0.23
Overall individual capillary to fiber ratio 1.16 ± 0.09, 1.62 ± 0.16 1.39 ± 0.09 1.63 ± 0.11
 Type I 1.31 ± 0.09§, 1.76 ± 0.17 1.57 ± 0.10 1.74 ± 0.11
 Type IIa 1.10 ± 0.08*, 1.44 ± 0.17 1.27 ± 0.10 1.50 ± 0.11
 Type IIx 1.02 ± 0.10* 1.16 ± 0.14 1.05 ± 0.10 1.19 ± 0.09

Data are presented as mean±SEM.

*,§,‖

Significant difference, compared to nonparetic leg muscle (*P <0.05, §P <0.01, P <0.001);

†,‡

significant difference, compared to NGT control muscle (P <0.05, P <0.01).